(Q41463105)

1 October 2017

1 reference

title

Cancer dormancy: opportunities for new therapeutic approaches (English)

1 reference

1 October 2017

author

Richard H. Scheuermann

series ordinal

1 reference

1 October 2017

Vitetta ES

1 reference

1 October 2017

Uhr JW

1 reference

1 October 2017

Street NE

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

1 October 2017

1 reference

1 October 2017

1 reference

1 October 2017

1 reference

1 October 2017

page(s)

505-509

1 reference

The Walter Hubert Lecture, 1982. Interaction of cancer and host

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

Collagen production by macrophages in tumour encapsulation and dormancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

Cancer progression and growth: relationship of paracrine and autocrine growth mechanisms to organ preference of metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

Dendritic cells: a major story unfolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

Exposing the immunology of naked DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

The incidence of late recurrence (greater than 10 years); an analysis of 536 consecutive cases of cutaneous melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

Clinical Significance of Minimal Residual Disease in Leukemia Detected by Polymerase Chain Reaction: Is Molecular Remission a Milestone for Achieving a Cure?

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

Sensitive detection of prostatic hematogenous tumor cell dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction.

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

How tumors become angiogenic

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

Adoptive T Cell Therapy of Tumors: Mechanisms Operative in the Recognition and Elimination of Tumor Cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

Tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

T-cell recognition of human melanoma antigens

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

Immunologically-mediated restraint of latent tumour metastases

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protection

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

Cancer dormancy: isolation and characterization of dormant lymphoma cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

Lymphoma models for B-cell activation and tolerance. II. Growth inhibition by anti-mu of WEHI-231 and the selection and properties of resistant mutants.

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

Isolation and characterization of anti-monosialoganglioside monoclonal antibody 19-9 class-switch variants

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

The distribution of secondary growths in cancer of the breast. 1889

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

Normal genetically mosaic mice produced from malignant teratocarcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

Adhesion or anti-adhesion in cancer: what matters more?

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

Lymphocyte homing and homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

TGF‐β stimulation of endometrial and breast‐cancer cell growth

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

Human melanoma cells express a functional interleukin-2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

Enhanced metastases of a mouse carcinoma after in vitro treatment with murine interferon gamma.

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

Tumour progression: random mutations or an integrated survival response to cellular stress conserved from unicellular organisms?

1 reference

https://api.crossref.org/works/10.1038%2FNM0597-505

7 January 2021

Identifiers

DOI

10.1038/NM0597-505

1 reference

1 October 2017

1 reference